Results 301 to 310 of about 475,892 (311)

Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban

Journal of Clinical Pharmacology, 2016
Wonkyung Byon, Frank LaCreta
exaly  

Clinical Pharmacology Basis of Deriving Dosing Recommendations for Dabigatran in Patients With Severe Renal Impairment

Journal of Clinical Pharmacology, 2012
exaly  

Effect of Renal Impairment on the Pharmacokinetics of Grepafloxacin

Clinical Pharmacokinetics, 2012
exaly  

Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 ( SGLT2 ) inhibitor, in subjects with renal impairment

Diabetes, Obesity and Metabolism, 2014
exaly  

Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment

Journal of Clinical Pharmacology, 2009
exaly  

Pituitary Hypothyroidism with Impaired Renal Function

BMJ, 1946
openaire   +3 more sources

Awoman with renal impairment

2015
Shilpa Jesudason, William M. Hague
openaire   +1 more source

Effect of Renal Impairment on the Pharmacokinetics of Intravenous Zanamivir

Clinical Pharmacokinetics, 2012
exaly  

Special Populations: Renal Impairment

2011
Gerard Sanderink, Gareth Shackleton, Jochen Maas, James Gilmour Morrison   +3 more
openaire   +1 more source

Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment

Epilepsy Research, 2014
exaly